SPDR Global Dow (DGT) Opções

Mellon posts pretty good stuff. He's bright.

Please ,can anyone tell me what the advantage is of "wide open eyes" ? Thank you !

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/486623364_1001203915441953_359692839513295248_n.jpg?_nc_cat=111&ccb=1-7&_nc_sid=127cfc&_nc_ohc=JrA2jAjhMOYQ7kNvgElce3S&_nc_oc=AdnFY7HGoQ48gIoUREMEUesd7SlmyB7AHpL22NCFRi47PNhkjw6f8dhyQ1DZAGAX9vFa-_ZsXSTToQtUvhBfvCDN&_nc_zt=23&_nc_ht=scontent-mia3-1.x

Hi Mellon. I just wanted to say to you sorry hearing about your dog. I just went through this about 3 months ago with my Murphy. It beat me up pretty good.

Anyways, sorry. Be good as you can. Hope it gets better.

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug
Piclidenoson with FDA & EMA-Approved Protocol

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs

Ramat Gan, Israel, March 24, 2025 (GLOBE NEWSWIR

Stop clogging up the board. People actually come here to read shit

And yet you keep posting.

Some things defy understanding.

"cafc will think there crazy and say the verdict stands!!!"

The CAFC has nothing to say regarding this licensing contract trial. This is 100 percent a CONTRACT case and nott a patent case. It is only reviewable by the Ninth Circus and the appeal will be there, nott the CAFC.

"This is the job of the SEC."

I'm pretty sure the SEC is broken and will not function, It had 16 1/2 years to help F&F and did what? Read its mission statement and then tell me what they have done for us. Not one damn thing!

Precision GelTM, as used in RadioGel™, solidifies at body temperature to hold Y-90 particles within a tumor, without penetrating cell membranes. The new provisional patent from January 2025 covers ‘retention, transport, and release’ of agents including large molecules, nanoparticles, and viruses. Fo

This is how you enforce a border

https://x.com/DC_Draino/status/1904253729395904797

If I'm right, BP's have a limited time in which they can afford to buy out, or partner with NWBO. I'm making the assumption that a BP isn't going to pay in excess of $100 billion.

I certainly don't know precisely how long it will take, but if it's clear that DCVax-L should be given a

Seems odd that nobody is posting about the status of the delinquent snpw filings. Didn’t snpw tweet they were working on them back in September 2024? Noting snpw didn’t report a single quarterly report in 2024 covering 2024 how about an update snpw. Now that you are tweeting, how about tweeting on

Another perfect storm for hype. CE rumors, medical high volume part orders, new facility announcements robotics, the ring company announcement of a B2B contract followed up by an actual contract in medics and CE waiver.

It’s getting late…amazing how one can think with clarity after 6

absolutely can’t forget! Good problem to have!!

Hope we hear more from the Gov.

Now think how this private Polariton company with a strategic Lightwave Logic material partnership - able of cornering the entire future modulator market over 400G per lane and replacing ‘ bulky’ TFLN on silicon wafers - could be IPO’d into a new ( multi billion dollar) public company? Happy to be

Nope!!!

The GOV warrant exercise price is $0.0001. So I call them free warrants. 

Rid Bondi! bring in Gates!

This is not the proper place to conduct business.
Also, it seems to me that the right hand doesn't know what the left hand is doing, in India.

In my novice/learning days, I remember GOLD at "$250.00", as a novice, limited to learning, these days, I feel the Metals will catch up faster as a market correction looms just ahead!

Therefore, I'm Long SLV ITM Calls through 2026

TSLA sales lag in Europe saw a silly

rally rewarding ungrowth Monday...

https://stocktwits.com/news-articles/markets/equity/tesla-registrations-in-europe-drops-steep-44-percent-in-february/ch7wZtrRb5U

Will be honest, have been looking at

th

Lehman Brothers Holdings PLC Update - February 2025
The administrators of LBH would like to provide creditors with an updated, illustrative financial outcomes for LBH.

In summary, based on certain predictions and assumptions and subject to the usual and important caveats which

Anixa secures US patent for ovarian cancer vaccine tech

https://ir.anixa.com/press-releases/detail/1073/anixa-biosciences-receives-notice-of-allowance-from-uspto